Biomet’s Struggling Spine Business Is Nearly Back On Track, CEO Says
This article was originally published in The Gray Sheet
Executive Summary
Biomet says recent management and infrastructure changes to its struggling spine division will allow the business to begin growing again by mid-2009
You may also be interested in...
Biomet Looks Abroad For Revenue Growth In Fiscal 2008
Biomet is highlighting growth overseas as a key driver of corporate revenues, and hip and knee reconstruction device sales in particular, reporting 16% top-line expansion for its fiscal fourth quarter (ended May 31)
Biomet Looks Abroad For Revenue Growth In Fiscal 2008
Biomet is highlighting growth overseas as a key driver of corporate revenues, and hip and knee reconstruction device sales in particular, reporting 16% top-line expansion for its fiscal fourth quarter (ended May 31)
Foreign Corrupt Practices Act: Device Industry Under Scrutiny
Federal prosecutors have begun targeting medical device companies in Foreign Corrupt Practices Act investigations